Becton, Dickinson and Company (BDXA)
Market Closed
30 Apr, 20:00
NYSE NYSE Primary $
59. 24
-1.36
-2.2442%
$
55.91B Market Cap
- P/E Ratio
3.8% Div Yield
6.15M Volume
- Eps
$ 60.6
Previous Close Want to track BDXA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
BDXA closed Thursday lower at $59.24, a decrease of -2.2442% from Wednesday's close, completing a monthly increase of 0% or $59.24. Over the past 12 months, BDXA stock gained 0%.
BDXA pays dividends to its shareholders, with the most recent payment made on May 01, 2020. The next estimated payment will be in 1 Aug 2020 on Aug 01, 2020 for a total of $0.7656.
The stock of the company had never split.
The company's stock is traded on one exchange.
Becton, Dickinson and Company (BDXA) FAQ
What is the stock price today?
The current price is $59.24.
On which exchange is it traded?
Becton, Dickinson and Company is listed on NYSE.
What is its stock symbol?
The ticker symbol is BDXA.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 3.8%.
What is its market cap?
As of today, the market cap is 55.91B.
Has Becton, Dickinson and Company ever had a stock split?
No, there has never been a stock split.
Becton, Dickinson and Company Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Thomas E. Polen Jr. CEO | NYSE Exchange | 075887109 CUSIP |
| US Country | 72,000 Employees | 14 Apr 2020 Last Dividend | - Last Split | - IPO Date |
Overview
Becton, Dickinson and Company, more commonly known as BD, stands as a global leader in the development, manufacture, and sale of a wide array of medical supplies, devices, laboratory equipment, and diagnostic products. Catering to healthcare institutions, physicians, life scientists, clinical laboratories, the pharmaceutical industry, and the general public across the world, the company is divided into three primary segments: BD Medical, BD Life Sciences, and BD Interventional. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD's commitment to advancing the world of health by improving medical discovery, diagnostics, and the delivery of care is evident through its innovative product lines and services.
Products and Services
- BD Medical: Offers a broad portfolio including peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology and care products, needle-free IV connectors, closed-system drug transfer devices, and hypodermic needles and syringes. This segment is committed to safety and efficiency in medication delivery and patient care, providing systems for medication compounding, automated dispensing, inventory management, and prefillable drug delivery.
- BD Life Sciences: Specializes in products and solutions designed for specimen and blood collection, automated blood culturing, molecular testing, and the identification and drug susceptibility testing of microorganisms. It also produces systems for liquid-based cytology, rapid diagnostic assays, and laboratory automation. In the realm of research, BD Life Sciences offers tools for cell analysis, gene expression, clinical oncology, immunology, and transplantation diagnostics, including fluorescence-activated cell sorters, analyzers, reagents, and kits.
- BD Interventional: Provides a wide range of medical devices and technologies aimed at improving surgical outcomes, managing infections, and enhancing patient care. This includes products for hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, surgical infection prevention, peripheral intervention, and urology and critical care, positioning BD as a leader in delivering innovative solutions for complex medical conditions and procedures.
Contact Information
Address: 1 Becton Drive
Phone: 201 847 6800
Website: https://www.bd.com
